several of such lung cell maintenance programs, in particular for lung endothelial cells, is disrupted by the toxic effect of chronic cigarette smoke in genetically susceptible patients, thus resulting in centrilobular emphysema. Specifically, we hypothesize that disappearance of lung alveoli resulting in centrilobular emphysema occurs by apoptosis after decreased expression or activity of lung vascular endothelial cell growth factor (VEGF) or its receptors due to smoking. In the present work, we focused on the effect of cigarette smoke extract (CSE) on VEGF gene expression, on endothelial cell apoptosis, and on the ratio of the transcription factors Sp1 and Sp3, which are involved in the regulation of VEGF receptor kinase domain receptor expression in endothelial cells.
mphysema is a chronic obstructive lung disease that is characterized by enlarged airspaces and is accompanied by alveolar destruction. It is generally thought that alveoli, once damaged, cannot be repaired in the adult lung. However, compensatory lung growth with increased complexity of alveolar septa in adult dogs was reported 1 after 54% of their lung was removed (right pneumonectomy), a finding that was not reported when 42% of their lung was removed (left pneumonectomy). This study suggested that given the appropriate signal(s), the lung might be capable of growing new alveoli. The growth of new alveoli also was reported in postnatal rats treated with systemic retinoic acid (RA) after the suppression of alveolar growth by dexamethasone. 2 However, the necessary components for alveolar septation are available in young rats. More recently, new alveolar growth was reported in adult rats that had been treated systemically with RA after intratracheal elastase-induced destruction of alveoli. 3 We asked whether the finding of new alveolar septation after RA treatment could be replicated and whether this repair produced an improvement in the lung function of rats whose lungs were damaged by elastase instillation, which is a model of emphysema.
Materials and Methods
Adult male Sprague-Dawley rats (90 days old at the start of the experiment) received either saline solution or 1,000 IU porcine elastase on days 0 and 14. The saline solution or elastase was delivered intratracheally using a microspray device (Penn Century; Philadelphia, PA) with a mean particle size of 15 to 20 m. Nine weeks after the first instillation, the rats were treated either with all-trans-RA (500 g/kg, intraperitoneally, daily for 2 weeks) in tetraglycol vehicle or with vehicle alone. At weeks 3, 6, 9, and 11, a dimensionless, noninvasive indicator of airflow obstruction (Buxco Electronics; Sharon, CT) was evaluated. 4 Just prior to killing the rats at week 11, a battery of pulmonary function tests was performed. 5 The tests included assessment of tidal breathing and breathing mechanics; respiratory system peak compliance, between 25 and Ϫ20 cm H 2 O; forced expiratory flow rates, between 25 and Ϫ40 cm H 2 O; multibreath diffusing capacity of the lung for carbon monoxide (Dlco), using a gas dilution of 1% carbon monoxide; functional residual capacity (FRC) using endtidal occlusion (Boyle's Law method); and other subdivisions of lung volume using neon gas dilution (0.5%). After testing, the rats were perfused with saline solution (lungs were inflated with air at 30 cm H 2 O), were given a volume history, and were intravascularly fixed (Karnovsky's fixative) at 12 cm H 2 O. Twenty-four hours later, the lungs were moved to formalin and were stored for sectioning. At 5 months, the fixed lungs were imaged with an electron-beam high-resolution CT scanner (model C-150XL; Imatron; South San Francisco, CA) using a standard 100-ms axial scan at 0.5 mm of resolution. Volume and density were determined after reconstruction using an extra sharp kernel. For all 
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Results
No significant effect on body weight was observed among groups throughout the 11-week study. During that period, the elastase-instilled rats always showed a larger pause than the saline solution-instilled mice, suggesting that the elastase-instilled rats had airflow obstruction. After 2 weeks of RA treatment, the rats treated with elastase plus vehicle showed significant progression of the obstruction, while those treated with elastase plus RA were unchanged from their previous value (Table 1) . Elastase instillation increased residual volume and total lung capacity compared to saline solution instillation. RA treatment significantly reduced these changes in lung volumes compared to treatment with elastase plus vehicle, while vital capacity was nonsignificantly reduced. Peak respiratory system compliance was increased and Dlco was decreased (after correction for differences in lung volumes), as would be expected in this emphysema model. Forced expiratory flow rates were also lower at all lung volumes. However, RA had no effect on these parameters in the elastase-instilled rats. Lung volume measurement by CT scan correlated highly with physiologic measurements of FRC (r ϭ 0.52; p Ͻ 0.03). Density measurements from the CT scan, obtained by detecting differences in trapped gas remaining in the lungs fixed with formalin, indicated that the lungs of rats treated with elastase plus RA had densities between those treated with elastase plus vehicle and those treated with saline solution. However, these differences were not significant, in part due to the smaller number of rats evaluated (n ϭ 3 to 7 per group).
Conclusions
Two intratracheal instillations of elastase caused a progressive emphysema-like lesion in rats that stabilized by 9 weeks (progression data not shown). This lesion was associated with significant changes in pulmonary function similar to those observed with human emphysema (increased lung volumes and compliance, decreased forced flows and Dlco). Surprisingly, 2 weeks of treatment with RA (intraperitoneally) resulted in mild improvements in lung volumes without an effect on compliance, forced flows, or Dlco. Evaluation of the lungs by CT scan indicated reduced density in elastase-treated lungs (as previously observed in human emphysema) and a restoration of the density toward control with RA treatment (not significant). Quantitative morphometry of the lung is required to determine whether new alveolar structures evolved with RA treatment. The data suggest that it may be possible to reverse a chronic degenerative lesion that is responsible for significant worldwide mortality. *TLC ϭ total lung capacity; VC ϭ vital capacity; RV ϭ residual volume; FVC ϭ forced vital capacity; PEF ϭ peak expiratory flow; MMEF ϭ mid-maximal expiratory flow; Cpk ϭ respiratory system peak compliance; HU ϭ Hounsfield units. n ϭ 9 or 10 per group except for CT measurements, which were n ϭ 3 to 7 per group. †Significant difference between elastase ϩ RA and elastase ϩ vehicle groups (P Ͻ 0.05).
transient airway obstruction in the rat after a chronic exposure to an ambient pattern of nitrogen dioxide. 
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n this summary of the clinical significance of the first day's presentations, I shall focus on three topics. The relative roles of collagen and elastin injury in the pathogenesis of emphysema, the cellular origin of elastases that may play a role in degrading elastin in emphysema, and the relative roles of bronchiolitis vs emphysema in causing airflow obstruction.
Collagen vs Elastin in Pathogenesis of Emphysema
The two main forms of emphysema in usual COPD are centrilobular and panacinar emphysema. Centrilobular emphysema begins with inflammation in the terminal and respiratory bronchioles, with subsequent enlargement of the adjacent respiratory airspaces. The resulting microbullae occupy a place in the center of the secondary lung lobule, hence the designation centrilobular emphysema. Airspace enlargement spreads outward from the center of the lobule. Panacinar emphysema arises by simultaneous, uniform destruction of the walls and enlargement of all the respiratory airspaces of the lung acinus. Hence, the designation panacinar. Panacinar emphysema is not associated with bronchiolitis.
The distribution of the two forms of emphysema in the lungs differs. Centrilobular emphysema predominates in the upper lung zones, panacinar emphysema in the lower lung zones. Both types of emphysema are found in COPD; about half the patients have both forms of emphysema and about 25% have largely one form or the other. Sections of centrilobular emphysema show broad bands of fibrosis, whereas centriacinar emphysema fails to show fibrosis. Biochemical studies of dissected lung tissue that is the site of centrilobular emphysema show increased concentration of collagen with normal concentration of elastin when the emphysema is mild; when the centrilobular emphysema is severe, there is a decrease in elastin concentration as well as increase in collagen concentration. Centriacinar emphysema shows a decrease in elastin concentration, with no change in collagen concentration compared to normal. Compliance is normal in lung tissue containing centrilobular emphysema. However, the microbullae of centrilobular emphysema show decreased compliance compared both with the lung that contains them and with normal lungs.
The varying distribution of centrilobular and panacinar emphysema within the lungs, the varying anatomy of the mild lesion, the different association with bronchiolitis, and the differences in collagen and elastin concentration in the two forms of emphysema, strongly supports the hypothesis that their pathogenesis is different.
Additional data for a role of collagen in the pathogenesis of emphysema comes from the studies of Kuhn more than 25 years ago, showing that collagen metabolism as well as elastin metabolism was altered after experimental pancreatic elastase injury of the lungs. Most recently, the studies have been published showing that transgenic mice expressing collagenase (MMP1) developed emphysema, thus implicating both collagen and collagenase in the pathogenesis of emphysema.
Pathogenesis of Centrilobular and Panacinar Emphysema
The Elastase-Antielastase Hypothesis: Panacinar emphysema in virtually pure form is the parenchymal lesion of ␣ 1 -antitrypsin deficiency. It has been posited for more than 35 years that elastase-antielastase imbalance is the cause of the panacinar emphysema. Briefly, the hypothesis is that elastases of inflammatory cell origin, mainly neutrophils and macrophages, overcome the antielastase defenses of the lungs, degrade elastic and other connective tissues of the lungs, and thereby give rise to emphysema. Among the many pieces of indirect evidence supporting this hypothesis is the increased inflammation in the BAL fluid of nonsmokers with ␣ 1 -antitrypsin deficiency and the even greater inflammatory response in smokers with this genetic disorder. Also, elastase-induced experimental emphysema is panacinar in type.
It has been known for many years that ␣ 1 -antitrypsin has neutrophil elastase as its main substrate. For this reason and because of the pulmonary neutrophilia of ␣ 1 -antitrypsin and of smokers, the neutrophil was thought to be the main source of elastase in the pathogenesis of emphysema. In recent years, the macrophage has also been shown to be the source of a metalloelastase, which is capable of degrading elastin. The macrophage is also the source of this enzyme's inhibitor, tissue inhibitor of metalloprotease. Recent elegant studies, using a transgenic mouse with deleted metalloprotease gene, showed that this enzyme is essential to the production of emphysema due to cigarette smoking in mice. These studies emphasize the possibility that the macrophage may be as important in the pathogenesis of human emphysema as the neutrophil.
The Inflammation-Fibrosis Hypothesis: The histologic and biochemical prominence of collagen in centrilobular
